TECH vs DVA — Key Metrics
| Metric | TECH (BIO-TECHNE CORP) | DVA (DAVITA INC) |
|---|---|---|
| Price | 72.47 | 174.92 |
| Market Cap | 11.36 Billion | 11.16 Billion |
| P/E (TTM) | 61.94 | 14.1 |
| P/B (Quarterly) | 5.385 | -19.012 |
| P/S (TTM) | 9.35 | 0.8 |
| Net Profit Margin (TTM) | 15.0 | 6.0 |
| Gross Margin (TTM) | 65.8 | 32.4 |
| ROE (TTM) | 8.9 | -123.6 |
| Revenue Growth YoY (TTM) | None | None |
Upfront Investment - S&P 500 Stock Comparison & AI Analysis
AI-powered analysis and comparison tools for S&P 500 stocks, helping investors make data-driven decisions with delayed market data and portfolio modeling.
Performance Comparison
AI Model Recommendation
TECH · BIO-TECHNE CORP
Greatly Underperform
DVA · DAVITA INC
Greatly Outperform
Recommendation Summary
Stock TECH is projected to greatly underperform the market, stock DVA is projected to greatly outperform the market. Upfront Recommendation: DVA.
Financial Metrics
Prices delayed ~15 min
| TECH | Metrics | DVA |
|---|---|---|
| $72.47 | Price | $174.92 |
| — | Market Capitalization | — |
| 61.94 | Price to Earnings Ratio | 14.1 |
| 9.35 | Price to Sales | 0.8 |
| 43.17 | Price to FCF Ratio | 6.93 |
| 14.22 | Price to Gross Profit | 2.46 |
| 15.27 | Price to Current Assets | 2.66 |